The PLAC Test
is the only blood test
cleared by the FDA
to aid in assessing risk for both
coronary heart disease (CHD)
and ischemic stroke associated
with atherosclerosis.
The PLAC® Test for Lp-PLA2 is the only blood test that helps identify hidden risk for heart attack and stroke. Early detection and more aggressive treatment can help prevent these events. 
Learn more about how you can run the PLAC Test in your lab. We answer technical questions you may have about the PLAC Test and how it can be used to help assess risk for heart attack and stroke.
Learn more about your risk for stroke and cardiovascular disease prevention. Now there is a simple blood test that can help uncover hidden risk for heart attack and stroke. Discover how the PLAC Test can help your physician assess your risk for and prevent these events. 
The PREvents ProgramSM is an exclusive program for clinicians to enhance and accelerate their clinical education
regarding advancements in the identification, management and treatment of cardiovascular disease (CVD). ![]()
Don't miss us at these events!
AAPP Summit on Concierge Medicine
Scottsdale, AZ | February 3, 2012
NLA Clinical Lipid Update
San Diego, CA | March 9, 2012